Intranasal esketamine treatment using Spravato® for treating severe, chronic depression

Intranasal esketamine treatment using Spravato® treats depression by being inhaled through the nose. It targets specific receptors in the brain and may help balance chemical interactions to alleviate symptoms of depression. If you are searching for innovative, proven, non-invasive treatments that can help alleviate the symptoms of chronic depression, ask your doctor to refer you for a consultation at UT Health San Antonio. Call 210-450-6450 or visit www.uthscsa.edu/patient-care/...